Burda Pavel, Vargova Jarmila, Curik Nikola, Salek Cyril, Papadopoulos Giorgio Lucio, Strouboulis John, Stopka Tomas
Biocev and Pathological Physiology, 1st Faculty of Medicine, Charles University in Prague, Czech Republic.
Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
PLoS One. 2016 Mar 24;11(3):e0152234. doi: 10.1371/journal.pone.0152234. eCollection 2016.
GATA-1 and PU.1 are two important hematopoietic transcription factors that mutually inhibit each other in progenitor cells to guide entrance into the erythroid or myeloid lineage, respectively. PU.1 controls its own expression during myelopoiesis by binding to the distal URE enhancer, whose deletion leads to acute myeloid leukemia (AML). We herein present evidence that GATA-1 binds to the PU.1 gene and inhibits its expression in human AML-erythroleukemias (EL). Furthermore, GATA-1 together with DNA methyl Transferase I (DNMT1) mediate repression of the PU.1 gene through the URE. Repression of the PU.1 gene involves both DNA methylation at the URE and its histone H3 lysine-K9 methylation and deacetylation as well as the H3K27 methylation at additional DNA elements and the promoter. The GATA-1-mediated inhibition of PU.1 gene transcription in human AML-EL mediated through the URE represents important mechanism that contributes to PU.1 downregulation and leukemogenesis that is sensitive to DNA demethylation therapy.
GATA-1和PU.1是两种重要的造血转录因子,它们在祖细胞中相互抑制,分别引导细胞进入红系或髓系谱系。PU.1在髓系造血过程中通过与远端URE增强子结合来控制自身表达,该增强子的缺失会导致急性髓系白血病(AML)。我们在此提供证据表明,GATA-1与PU.1基因结合并抑制其在人类AML-红白血病(EL)中的表达。此外,GATA-1与DNA甲基转移酶I(DNMT1)共同通过URE介导对PU.1基因的抑制。对PU.1基因的抑制涉及URE处的DNA甲基化及其组蛋白H3赖氨酸-K9的甲基化和去乙酰化,以及其他DNA元件和启动子处的H3K27甲基化。GATA-1通过URE介导的对人类AML-EL中PU.1基因转录的抑制是导致PU.1下调和白血病发生的重要机制,而白血病发生对DNA去甲基化治疗敏感。